These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32759366)

  • 1. Comparison of In Vitro to In Vivo Extrapolation Approaches for Predicting Transporter-Mediated Hepatic Uptake Clearance Using Suspended Rat Hepatocytes.
    Li N; Badrinarayanan A; Li X; Roberts J; Hayashi M; Virk M; Gupta A
    Drug Metab Dispos; 2020 Oct; 48(10):861-872. PubMed ID: 32759366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-Mediated Uptake Improves Human Clearance Prediction for Hepatic Uptake Transporter Substrates Aiding a Mechanistic In Vitro-In Vivo Extrapolation (IVIVE) Strategy in Discovery Research.
    Li N; Badrinarayanan A; Ishida K; Li X; Roberts J; Wang S; Hayashi M; Gupta A
    AAPS J; 2020 Nov; 23(1):1. PubMed ID: 33196949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
    Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Utility of PXB Chimeric Mice for Predicting Human Liver Partitioning of Hepatic Organic Anion-Transporting Polypeptide Transporter Substrates.
    Feng B; Pemberton R; Dworakowski W; Ye Z; Zetterberg C; Wang G; Morikawa Y; Kumar S
    Drug Metab Dispos; 2021 Mar; 49(3):254-264. PubMed ID: 33376106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Organic Anion Transporting Polypeptide-Mediated Clearance in the Beagle Dog: Assessing In Vitro-In Vivo Relationships and Applying Cross-Species Empirical Scaling Factors to Improve Prediction of Human Clearance.
    Matsunaga N; Ufuk A; Morse BL; Bedwell DW; Bao J; Mohutsky MA; Hillgren KM; Hall SD; Houston JB; Galetin A
    Drug Metab Dispos; 2019 Mar; 47(3):215-226. PubMed ID: 30593544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Method to Predict In Vivo Liver-to-Plasma K
    Riccardi K; Lin J; Li Z; Niosi M; Ryu S; Hua W; Atkinson K; Kosa RE; Litchfield J; Di L
    Drug Metab Dispos; 2017 May; 45(5):576-580. PubMed ID: 28258068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrapolation of In Vivo Hepatic Clearance from In Vitro Uptake Clearance by Suspended Human Hepatocytes for Anionic Drugs with High Binding to Human Albumin: Improvement of In Vitro-to-In Vivo Extrapolation by Considering the "Albumin-Mediated" Hepatic Uptake Mechanism on the Basis of the "Facilitated-Dissociation Model".
    Kim SJ; Lee KR; Miyauchi S; Sugiyama Y
    Drug Metab Dispos; 2019 Feb; 47(2):94-103. PubMed ID: 30504137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
    Poulin P; Haddad S
    J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Transporter-Mediated Rosuvastatin Hepatic Uptake Clearance and Drug Interaction in Humans Using Proteomics-Informed REF Approach.
    Kumar V; Yin M; Ishida K; Salphati L; Hop CECA; Rowbottom C; Xiao G; Lai Y; Mathias A; Chu X; Humphreys WG; Liao M; Nerada Z; Szilvásy N; Heyward S; Unadkat JD
    Drug Metab Dispos; 2021 Feb; 49(2):159-168. PubMed ID: 33051248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Phenomenon of Albumin-Mediated Hepatic Uptake of Organic Anion Transport Polypeptide Substrates: Prediction of the In Vivo Uptake Clearance from the In Vitro Uptake by Isolated Hepatocytes Using a Facilitated-Dissociation Model.
    Miyauchi S; Masuda M; Kim SJ; Tanaka Y; Lee KR; Iwakado S; Nemoto M; Sasaki S; Shimono K; Tanaka Y; Sugiyama Y
    Drug Metab Dispos; 2018 Mar; 46(3):259-267. PubMed ID: 29298773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Human Plasma on Hepatic Uptake of Organic Anion-Transporting Polypeptide 1B Substrates: Studies Using Transfected Cells and Primary Human Hepatocytes.
    Bi YA; Ryu S; Tess DA; Rodrigues AD; Varma MVS
    Drug Metab Dispos; 2021 Jan; 49(1):72-83. PubMed ID: 33139461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake.
    Fujino R; Hashizume K; Aoyama S; Maeda K; Ito K; Toshimoto K; Lee W; Ninomiya SI; Sugiyama Y
    Eur J Pharm Sci; 2018 Dec; 125():181-192. PubMed ID: 30287410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
    Poulin P
    J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Unbound Partition Coefficient and in Vitro-in Vivo Extrapolation for SLC13A Transporter-Mediated Uptake.
    Riccardi K; Li Z; Brown JA; Gorgoglione MF; Niosi M; Gosset J; Huard K; Erion DM; Di L
    Drug Metab Dispos; 2016 Oct; 44(10):1633-42. PubMed ID: 27417179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Hepatic Uptake in Human and Monkey Hepatocytes in the Presence and Absence of Serum Protein and Its In Vitro to In Vivo Extrapolation.
    Liang X; Park Y; DeForest N; Hao J; Zhao X; Niu C; Wang K; Smith B; Lai Y
    Drug Metab Dispos; 2020 Dec; 48(12):1283-1292. PubMed ID: 33037043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Plasma Protein Binding in Drug Clearance Prediction: A Data Base Analysis of Published Studies and Implications for In Vitro-In Vivo Extrapolation.
    Francis LJ; Houston JB; Hallifax D
    Drug Metab Dispos; 2021 Mar; 49(3):188-201. PubMed ID: 33355201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Unified Approach to Predict Human Hepatic Clearance for Both Enzyme- and Transporter-Mediated Mechanisms Using Suspended Human Hepatocytes.
    Riccardi KA; Tess DA; Lin J; Patel R; Ryu S; Atkinson K; Di L; Li R
    Drug Metab Dispos; 2019 May; 47(5):484-492. PubMed ID: 30787098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
    Poulin P; Haddad S
    J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving approaches on measurements and applications of intracellular free drug concentration and Kp
    Di L; Riccardi K; Tess D
    Expert Opin Drug Metab Toxicol; 2021 Jul; 17(7):733-746. PubMed ID: 34058926
    [No Abstract]   [Full Text] [Related]  

  • 20. Uridine 5'-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) Prediction of Hepatic Clearance of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Substrate Telmisartan by Glucuronidation Using In Vitro-In Vivo Extrapolation (IVIVE).
    Gabor-Worwa E; Kowal-Chwast A; Gaud N; Gogola D; Littlewood P; Smoluch M; Brzózka K; Kus K
    Eur J Drug Metab Pharmacokinet; 2024 May; 49(3):393-403. PubMed ID: 38642299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.